Irinotecan in Treating Patients With Recurrent Glioma
Study Information
Alliance Study ID: NCCTG-967251
NCT Study ID (ClinicalTrials.gov): NCT00003134
Disease or Cancer Type: Brain / Central Nervous System Cancer
Alliance Study Chair: Jan C. Buckner, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have recurrent glioma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information